Suite 318, Level 3 Ramsay Specialist Centre Newdegate Street Greenslopes QLD 4120 Get Directions
Dr Andrew Barbour is a general surgeon who specialises in upper gastrointestinal, pancreatic, melanoma and sarcoma surgery. Dr Barbour accepts referrals for the following conditions:
Biography
Professor Andrew Barbour specialises in the treatment of oesophageal, gastric, pancreatic and adrenal diseases, as well as melanoma and soft tissue tumours.
He has expertise in minimally invasive treatments for oesophageal, gastric, pancreatic and adrenal, including thoracoscopic/laparoscopic oesophagectomy, laparoscopic anti-reflux surgery (fundoplication), laparoscopic gastrectomy, laparoscopic pancreatectomy, and bariatric surgery. He also has expertise in robot-assisted minimally invasive surgery using the Da Vinci system including oesophagectomy.
He has long standing interests in the management of melanoma and soft tissue tumours. Melanoma in particular has seen significant changes in management over the last decade with much needed improvements in survival. Prof Barbour is involved in studies which seek to further improve patient outcomes.
Professor Andrew Barbour academic interests with The University of Queensland have encompassed the areas of 1) clinical research, including randomised controlled clinical trials, 2) laboratory based research, including molecular biology pertinent to upper gastrointestinal disease, pancreatic cancer and melanoma, 3) translational research integrating the laboratory and clinical domains.
As a clinical researcher, Prof Barbour has been active in the conduct of clinical trials at Phase I, II and III levels. He lead trials in the use of biomarker-directed therapy in oesophageal cancer (DOCTOR Trial) and the use of pre-operative chemotherapy in pancreatic cancer (GAP Trial), funded by the NH&MRC. He is also an investigator on a subsequent pancreatic cancer study.
Prof Barbour is a translational researcher at the Diamantina Institute, The University of Queensland. He is the head of Surgical Oncology Lab at the Diamantina Institute. His research has focused on using genomic, epigenomic, mRNA expression and next generation sequencing data to classify oesophageal adenocarcinoma (OAC), pancreatic cancer and melanoma and to identify biomarkers of outcome.